Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Workshop on late renal allograft dysfunction.

Catherine M Meyers1, Allan D Kirk

  • 1Division of Kidney, Urologic and Hematologic Diseases, National Institutes of Health, Department of Health and Human services, Bethesda, Maryland, USA. cm420i@nih.gov

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|June 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Reported Flourishing Among U.S. Surgeons: A National Physician Survey.

Journal of the American College of Surgeons·2026
Same author

American Journal of Transplantation at 25 years: A trusted voice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Dual costimulation blockade with the CD154-specific fusion protein dazodalibep and belatacept for prophylaxis of kidney allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

A Report of Four Depletional Induction Strategies in Non-Human Primate Islet Xenotransplantation.

Xenotransplantation·2026
Same author

Costimulatory blockade and infectious risk in solid organ transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Corrigendum to "Antibodies to angiotensin II type 1 receptor and endothelin type A receptor are associated with cytokine production enriched for type 2 immune response and antibody production in pediatric kidney transplant recipients" [American Journal of Transplantation. Volume 25, Issue 11, November 2025, Pages 2329-2344].

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Late allograft dysfunction is a major challenge in renal transplantation, with varied functional decline rates. Understanding fibrosis mechanisms and identifying surrogate markers are crucial for improving long-term transplant outcomes.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Late allograft dysfunction persists despite improved acute injury management and short-term survival in renal transplantation.
  • Individual renal function decline rates vary significantly, with distinct predictors for early and late functional loss.

Framework:

  • Long-term renal transplantation outcome studies are hampered by incomplete datasets for clinical endpoint assessment.
  • Heterogeneous factors contribute to progressive allograft injury, necessitating routine biopsy sampling for comprehensive injury characterization.

Implementation:

  • Investigating mechanisms of renal fibrosis in response to injury, in both experimental and human systems, is key to understanding chronic allograft damage.
  • Cell senescence gene regulation and epithelial-to-mesenchymal transition are likely relevant to renal allograft dysfunction studies.

Related Experiment Videos

Implications:

  • Advances in biological sample analysis can identify and validate surrogate markers for allograft function.
  • Identifying reliable markers will facilitate future interventional trials to improve long-term renal transplant success.